THURSDAY, April 4, 2024 (HealthDayNews) — Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study, and the drug “will no longer be available for new…  read on >  read on >

Desks that require folks to stand or move as they work also might help them produce better results on the job, a new study suggests. People’s brains became sharper when working at a desk that made them stand, step or walk rather than sit, results show. Reasoning scores in particular improved when at an active…  read on >  read on >